Man-Son-Hing M, Wells G
Division of Geriatric Medicine, University of Ottawa, Ontario, Canada.
BMJ. 1995 Jan 7;310(6971):13-7. doi: 10.1136/bmj.310.6971.13.
To assess quantitatively the efficacy of quinine (as quinine sulphate) compared with placebo in the treatment of nocturnal leg cramps.
A meta-analysis of six randomised, double blind, crossover trials.
Randomised trials that were available as of April 1994.
A total of 107 general ambulatory patients who suffered from regular nocturnal leg cramps from six clinical trials.
Data from individual patients were used to calculate point estimates and 95% confidence intervals for each of the outcome measures reported by these studies. Treatment with quinine resulted in a significant reduction in the number of cramps for a four week period compared with placebo (8.83 fewer cramps; 95% confidence interval 4.16 to 13.49). Treatment with quinine reduced the number of nights with cramps by 27.4% (24.0% to 30.8%) compared with placebo. Treatment did not produce a significant change in the severity or duration of individual nocturnal leg cramps. Side effects were uncommon.
The results indicate that quinine can prevent nocturnal leg cramps in general ambulatory populations. Given the possible serious side effects of treatment with quinine, the benefits and risks in patients taking this drug should be closely monitored.
定量评估硫酸奎宁与安慰剂相比治疗夜间腿部痉挛的疗效。
对六项随机、双盲、交叉试验进行荟萃分析。
截至1994年4月可获取的随机试验。
来自六项临床试验的共107名经常遭受夜间腿部痉挛的普通门诊患者。
使用个体患者数据计算这些研究报告的每个结局指标的点估计值和95%置信区间。与安慰剂相比,奎宁治疗在四周期间导致痉挛次数显著减少(痉挛次数减少8.83次;95%置信区间4.16至13.49)。与安慰剂相比,奎宁治疗使有痉挛的夜晚数量减少了27.4%(24.0%至30.8%)。治疗未使个体夜间腿部痉挛的严重程度或持续时间产生显著变化。副作用不常见。
结果表明奎宁可预防普通门诊人群的夜间腿部痉挛。鉴于奎宁治疗可能产生严重副作用,服用该药物的患者的获益与风险应密切监测。